Silymarin
Care Group Health Care System
Pharmacology entry for Silybum marianum
Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H.
Cisplatin nephrotoxicity and protection by silibinin.
http://www.ncbi.nlm.nih.gov/Abstract
Scambia G, De Vincenzo R, Ranelletti FO, Panici PB, Ferrandina G, D'Agostino G, Fattorossi A, Bombardelli E, Mancuso S.
Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin.
http://www.ncbi.nlm.nih.gov/Abstract
Invernizzi R, Bernuzzi S, Ciani D, Ascari E.
Silymarine during maintenance therapy of acute promyelocytic leukemia.
http://www.ncbi.nlm.nih.gov/Abstract
Bokemeyer C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H, Lentzen H.
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.